GSK
SUPPORTING THE BUSINESS CASE FOR A MAJOR FACTORY IN ITALY
CLIENT

GSK addressed their planning needs by utilising simulation modelling for the new bio-pharma sterile product line. This approach created a highly accurate digital twin of the future production process.
The simulation model functioned as a testing ground for GSK. They could explore various what-if scenarios to understand the impact on production capacity and operating costs.
This powerful tool provided specific answers to critical questions:
- Machine quantity: The optimal number of machines needed for the line.
- Machine technology: The most suitable technology for the chosen machines.
- Operational setup: The ideal staffing levels, batching patterns, and other operational factors.
By leveraging simulation modeling, GSK gained valuable insights before committing to physical infrastructure and equipment.
GSK are now entering the construction phase. We are proud that modelling has helped support this.
GSK's the top three benefits:
- Faster approval timeline – the trust in the modelling outputs has smoothed the stage gate approval of the concept and allowed to move faster into the next project phase.
- Increased confidence in the amount of equipment required for the new production line that ultimately led to reduction in CAPEX by a double digit number.
- Ability to evaluate over 200 different business scenarios in a short amount of time.
Our tool has the capability to deliver continued value to the project so that in the future it will be possible to further evaluate capacity requirements as function of the demand forecast variability. The model also has the capability to be extended to people and material flow for the final operational layout.

Contact us
Discover how we can help solve your greatest challenges.
We’re a team of innovators with the skills and ideas to help companies create amazing solutions.